SUNSHINE PHARMA (06887): Zhang Zhiyong selected as employee director.
Dongyang Guangyao (06887) announced that Mr. Zhang Zhiyong was elected as an employee director (executive director) of the second board of directors after being selected by the company's employees' representative assembly on June 18, 2026. His term of office shall commence on the date of approval by the annual general meeting of shareholders of the second board of directors (i.e. June 18, 2026) and shall expire upon the completion of the term of office of the second board of directors.
SUNSHINE PHARMA (06887) announced that on June 18, 2026, Mr. Zhang Zhiyong was elected as an employee director (executive director) of the second board of directors after being selected by the company's employee representative assembly. His term will start on the day of approval by the annual general meeting of shareholders of the second board of directors (i.e. June 18, 2026) and will last until the expiration of the term of the second board of directors.
Related Articles
China Securities Co., Ltd.: After a short-term rebound, A shares may fluctuate. AI computing power remains the main trend in the medium to long term.
AMASSE CAPITAL (08168): Shareholders demand the removal of current directors.
CITIC SEC: Rate hikes difficult to shake AI valuation, non-AI weakness needs to break through its own narrative.
China Securities Co., Ltd.: After a short-term rebound, A shares may fluctuate. AI computing power remains the main trend in the medium to long term.
AMASSE CAPITAL (08168): Shareholders demand the removal of current directors.
CITIC SEC: Rate hikes difficult to shake AI valuation, non-AI weakness needs to break through its own narrative.
RECOMMEND
